Randomized Study Comparing Genz-644470, Placebo, and Sevelamer Carbonate in Chronic Kidney Disease Patients on Hemodialysis
Public ClinicalTrials.gov record NCT00853242. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study Using Genz-644470 and Sevelamer Carbonate in Hyperphosphatemic Chronic Kidney Disease Patients on Hemodialysis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this clinical study is to compare the effects of Genz-644470 with the effects of placebo and sevelamer carbonate (Renvela®) on the reduction of serum phosphorus in hyperphosphatemic chronic kidney disease participants on hemodialysis.
Study identification
- NCT ID
- NCT00853242
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 349 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2009 (Type not available)
- Primary completion
- Aug 2009 (Actual)
- Completion
- Aug 2009 (Actual)
- Last update posted
- May 1, 2015
2009
United States locations
- U.S. sites
- 52
- U.S. states
- 26
- U.S. cities
- 52
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Alexander City | Alabama | — | — |
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Hot Springs | Arkansas | — | — |
| Not listed | Bakersfield | California | — | — |
| Not listed | Los Angeles | California | — | — |
| Not listed | Paramount | California | — | — |
| Not listed | Pembroke Pines | California | — | — |
| Not listed | Porterville | California | — | — |
| Not listed | Riverside | California | — | — |
| Not listed | San Dimas | California | — | — |
| Not listed | Whittier | California | — | — |
| Not listed | Denver | Colorado | — | — |
| Not listed | Washington D.C. | District of Columbia | — | — |
| Not listed | Hudson | Florida | — | — |
| Not listed | Ocala | Florida | — | — |
| Not listed | Tampa | Florida | — | — |
| Not listed | Augusta | Georgia | — | — |
| Not listed | Marietta | Georgia | — | — |
| Not listed | Gurnee | Illinois | — | — |
| Not listed | Indianapolis | Indiana | — | — |
| Not listed | Wichita | Kansas | — | — |
| Not listed | Lexington | Kentucky | — | — |
| Not listed | Bethesda | Maryland | — | — |
| Not listed | Pontiac | Michigan | — | — |
| Not listed | Southfield | Michigan | — | — |
| Not listed | Brookhaven | Mississippi | — | — |
| Not listed | Gulfport | Mississippi | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Kearney | Nebraska | — | — |
| Not listed | Las Vegas | Nevada | — | — |
| Not listed | Bellmore | New York | — | — |
| Not listed | Brooklyn | New York | — | — |
| Not listed | Buffalo | New York | — | — |
| Not listed | New York | New York | — | — |
| Not listed | Port Washington | New York | — | — |
| Not listed | The Bronx | New York | — | — |
| Not listed | Asheville | North Carolina | — | — |
| Not listed | Cincinnati | Ohio | — | — |
| Not listed | Doylestown | Pennsylvania | — | — |
| Not listed | Lancaster | Pennsylvania | — | — |
| Not listed | Lewistown | Pennsylvania | — | — |
| Not listed | Philadelphia | Pennsylvania | — | — |
| Not listed | Charleston | South Carolina | — | — |
| Not listed | Orangeburg | South Carolina | — | — |
| Not listed | Sumter | South Carolina | — | — |
| Not listed | Columbia | Tennessee | — | — |
| Not listed | Knoxville | Tennessee | — | — |
| Not listed | Nashville | Tennessee | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | Alexandria | Virginia | — | — |
| Not listed | Glendale | Wisconsin | — | — |
| Not listed | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00853242, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 1, 2015 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00853242 live on ClinicalTrials.gov.